- Sala M, Domingo L, Louro J, Torá-Rocamora I, Baré M, Ferrer J, Carmona-Garcia MC, Barata T, Román M, Macià F,Castells X; for the CAMISS Study Group.Survival and disease-free survival by breast density and phenotype in interval breast cancers. Cancer Epidemiol Biomarkers Prev, 2018 [Epub ahead of print].
- Román M, Caicoya M, Espinàs J, Sala M, Torá-Rocamora I, Quinta MJ, Vernet M, Saladié F, Romero A, Sánchez M, Baré M, Vidal C, Servitja S, Natal C, Corominas J, Ferrer J, Rodríguez-Arana A, Castells X; BELE Project study group.Clinical and histological characteristics of breast cancers in women with previous pathological diagnosis of benign breast disease in Spain. Breast J 2018 [Epub ahead of print]
- García-Gutierrez S, Orive M, Sarasqueta C, Legarreta MJ, Gonzalez N, Redondo M, Rivero A, Serrano-Aguilar P, Castells X, Quintana JM, Sala M; REDISSEC-CaMISS group. Health services research in patients with breast cancer (CAMISS-prospective): study protocol for an observational prospective study. BMC Cancer. 2018 Jan 8;18(1):54.
- Martínez-Alonso M, Carles-Lavila M, Pérez-Lacasta MJ, Pons-Rodríguez A, Garcia M, Rué M; InforMaGroup. Assessment of the effects of decision aids about breast cancer screening: a systematic review and meta-analysis. BMJ Open.2017 Oct 6;7(10)
- Carles M, Martínez-Alonso M, Pons A, Pérez-Lacasta MJ1, Perestelo-Pérez L, Sala M, Vidal C, Garcia M, Toledo-Chávarri A, Codern N, Feijoo-Cid M, Romero A, Pla R, Soler-González J, Castells X, Rué M; InforMaGroup. The effect of information about the benefits and harms of mammography on women’s decision-making: study protocol for a randomized controlled trial. Trials. 2017 Sep 12;18(1):426.
- Parés-Badell O, Banqué M, Macià F, Castells X, Sala M. Impact of comorbidity on survival by tumour location: Breast, colorectal and lung cancer (2000-2014). Cancer Epidemiol. 2017 Aug;49:66-74.
- Posso M, Corominas JM, Serrano L, Román M, Torá-Rocamora I, Domingo L, Romero A, Quintana MJ, Vernet-Tomas M, Baré M, Vidal C, Sánchez M, Saladié F, Natal C, Ferrer J, Servitja S, Sala M, Castells X. Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case-control study. Cancer Med. 2017 Jun;6(6):1482-1489.
- Toledo-Chávarri A, Rué M, Codern-Bové N, Carles-Lavila M, Perestelo-Pérez L, Pérez-Lacasta MJ, Feijoo-Cid M; InforMa Study Group. A qualitative study on a decision aid for breast cancer screening: Views from women and health professionals. Eur J Cancer Care (Engl).2017 May;26(3).
- Román M, Quintana MJ, Ferrer J, Sala M,Castells X. Cumulative risk of breast cancer screening outcomes according to the presence of previous benign breast disease and family history of breast cancer: supporting personalised screening. Brit J Cancer. 2017 May;116(11):1480-1485
- Romero A, Torà-Rocamora I, Baré M, Barata T, Domingo L, Ferrer J, Torà N, Comas M, Merenciano C, Macià F, Castells X, Sala M and CAMISS Study Group. Prevalence of persistent pain after breast cancer treatment by detection mode among participants in population-based screening programs. BMC Cancer (2016) 16:735.
- Castells X, Torá-Rocamora I, Posso M, Román M, Vernet-Tomas M, Rodríguez-Arana A, Domingo L, Vidal C, Baré M, Ferrer J, Quintana MJ, Sánchez M, Natal C, Espinàs JA, Saladié F, Sala M. Risk of breast cancer in women with false-positive results according to mammographic features. Radiology. 2016 Aug;280(2):379-86.
- Baré M, Torà N, Salas D, Sentís M, Ferrer J, Ibáñez J, Zubizarreta R, Sarriugarte G, Barata T, Domingo L, Castells X, Sala M. Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program. Breast Cancer Res Treat. 2015 Nov;154(2):403-15.
- Sala M, Domingo L, Macià F, Comas M, Burón A, Castells X. Does digital mammography suppose an advance in early diagnosis? Trends in performance indicators 6 years after digitalization. Eur Radiol. 2015 Mar;25(3):850-9.
- Castells X, Domingo L, Corominas JM, Torá-Rocamora I, Quintana MJ, Baré M, Vidal C, Natal C, Sánchez M, Saladié F, Ferrer J, Vernet M, Servitja S, Rodríguez-Arana A, Roman M, Espinàs JA, Sala M. Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program. Breast Cancer Res Treat. 2015 Jan;149(1):237-44.
- Blanch J, Sala M, Ibáñez J, Domingo L, Fernández B, Otegi A, Barata T, Zubizarreta R, Ferrer J, Castells X, Rué M, Salas D, the Interval Cancer (INCA) Study Group. Impact of risk factors on different interval cancer subtypes in a population-based breast cancer screening programme. PLoS One. 2014 Oct 21;9(10):e110207.
- Comas M, Arrospide A, Mar J, Sala M, Vilaprinyó E, Hernández C, Cots F, Martínez J, Castells X. Budget impact analysis of switching to digital mammography in a population-based breast cancer screening program: a discrete event simulation model. PLoS One. 2014 May 15;9(5).
- Vilaprinyó, Forné C, Carles M, Sala M, Pla R, Castells X, Domingo L, Rué M, the Interval Cancer (INCA) Study Group. Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer. PLos One. 2014 Jan; 9(2): e86858.
- Domingo L, Salas D, Zubizarreta R, Baré M, Sarriugarte G, Barata T, Ibáñez J, Blanch J, Puig-Vives M, Fernández AB, Castells X, Sala M. Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain. Breast Cancer Research. 2014 16:R3.
- Román M, Rué M, Sala M, Ascunce N, Baré M, Baroja A, De la Vega M, Galcerán J, Natal C, Salas D, Sánchez-Jacob M, Zubizarreta R, Castells X. Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study. PLoS One. 2013 Dec23;8(12):e83121.